Search results for "Vaccinations"
QI project helps raise vaccination rates
With patients likely to decline all vaccinations, of any kind, due mainly to concerns about safety or adverse effects, physicians opted to work with ACP's “I Raise the Rates” initiative as a quality improvement project.
https://immattersacp.org/archives/2018/02/qi-project-helps-raise-vaccination-rates.htm
1 Feb 2018
Correction to ‘ACIP releases 2024 Adult Immunization Schedule featuring new vaccines’
In the Jan. 16, 2024, issue, the article on the 2024 Adult Immunization Schedule incorrectly summarized the recommendations for respiratory syncytial virus (RSV) vaccination.
https://immattersacp.org/weekly/archives/2024/01/23/6.htm
23 Jan 2024
RSV present in 8.7% of outpatient COPD exacerbations, study finds
Of 310 chronic obstructive pulmonary disease (COPD) exacerbations at clinics in the United Kingdom and the Netherlands analyzed in a recent study, 27 were related to respiratory syncytial virus (RSV).
https://immattersacp.org/weekly/archives/2024/03/26/2.htm
26 Mar 2024
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2021/09/latest-updates-on-acps-priorities-initiatives.htm
1 Sep 2021
New findings on antiviral flu treatment
A recent study raises doubts about whether oseltamivir should be promoted as a way to prevent hospitalization in low-risk patients.
https://immattersacp.org/archives/2023/11/new-findings-on-antiviral-flu-treatment.htm
1 Nov 2023
Register now for ACP's Internal Medicine Meeting 2022: Mastering Medicine Together
Internal medicine's most comprehensive educational event returns, in person, at Chicago's McCormick Convention Center, April 28 to 30. Virtual access will also be available.
https://immattersacp.org/weekly/archives/2021/10/26/5.htm
26 Oct 2021
Comprehensive study finds vaccines remarkably safe
The most common safety issue that resulted in label changes for vaccines was a restriction on the population to be vaccinated, such as pregnant or immunocompromised patients.
https://immattersacp.org/weekly/archives/2020/07/28/4.htm
28 Jul 2020
Latest COVID-19 research details local vaccine reactions, ineffective outpatient treatments
A case series described delayed skin reactions to vaccination, and randomized trials indicated that ivermectin, azithromycin, and convalescent plasma didn't help mildly ill patients. Several studies focused on the increase in alcohol use during the pandemic.
https://immattersacp.org/weekly/archives/2021/03/09/1.htm
9 Mar 2021
Regulatory changes for COVID-19 vaccine; data on waning immunity, outpatient therapies
The FDA authorized vaccinating children, the NIH supported concurrent use of flu and COVID-19 shots, and the CDC addressed a fourth dose of COVID-19 vaccine for the immunocompromised. Trials found benefit from a new monoclonal antibody and an old antidepressant for high-risk outpatients.
https://immattersacp.org/weekly/archives/2021/11/02/1.htm
2 Nov 2021
Distribution plans, data on vaccines; NIH cautious on latest antibody treatment
The Advisory Committee on Immunization Practices chose clinicians and long-term care residents for priority vaccination, while ACP offered additional input on the topic. The NIH said that casirivimab plus imdevimab should not be standard of care, and the CDC offered recommendations on shortening quarantine.
https://immattersacp.org/weekly/archives/2020/12/08/1.htm
8 Dec 2020